Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Grupo De Estudos Da Retina

Clinical trials sponsored by Grupo De Estudos Da Retina, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Longer-Lasting eye injection could cut treatment visits for macular disease Results expected Sep 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

Longer-Lasting eye injection could cut treatment visits for macular disease

Disease control Not yet recruiting

This study looks at whether switching to a higher-dose eye injection called aflibercept 8 mg can allow people with neovascular age-related macular degeneration (nAMD) or diabetic macular oedema (DME) to go longer between treatments. It follows adults in Portugal who have already …

Sponsor: Grupo de Estudos da Retina • Aim: Disease control

Last updated Aug 14, 2026 00:00 UTC